Serum levels and pharmacokinetic of rituximab in bi-weekly R-CHOP in elderly patients with DLBCL treated in the RICOVER-60 trial.

被引：4

作者：

Reiser, Marcel

Wenger, Michael K.

Nickenig, Christina

Peter, N.

Kuhn, Christian

Metzner, Bemd

Theisohn, Martin

Pfreundschuh, Michael

机构：

[1] Univ Klinikum, Innere Med Klin, Cologne, Germany

[2] F Hoffmann La Roche Ltd, Roche Pharma, Basel, Switzerland

[3] Univ Klinikum, Med Klin & Poliklin 3, Munich, Germany

[4] Carl Thieme Klin, Med Klin Abt, Cottbus, Germany

[5] Univ Klinikum, Med Klin 3, Mannheim, Germany

[6] Klin Onkol & Haematol, Oldenburg, Germany

[7] Univ Klinikum, Inst Pharmacol, Cologne, Germany

[8] Univ Klinikum, Med Klin 1, Homburg, Germany

来源：

关键词：

D O I：

10.1182/blood.V108.11.2748.2748

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2748

引用

页码：778A / 778A

页数：1